Tuesday, June 21, 2016

BRIEF-Vivus receives notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets

* Received notice from Hetero USA that it has filed with

U.S. FDA ANDA for generic versions of all strengths of Stendra

tablets

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)